acute radiation syndrome


Also found in: Dictionary, Thesaurus, Medical, Acronyms, Wikipedia.

acute radiation syndrome

[ə′kyüt ′rād·ē′a·shən ′sin‚drōm]
(medicine)
A complex of symptoms involving the intestinal tract, blood-forming organs, and skin following whole-body irradiation.
References in periodicals archive ?
Hematopoietic recovery of acute radiation syndrome by human superoxide dismutase-expressing umbilical cord mesenchymal stromal cells.
It is also being developed, with funding by the US Government, as a medical countermeasure against chemical and radiological weapons, where its initial target indications are as a protective agent against the effects of acute radiation syndrome and delayed effects of acute radiation exposure.
Caused by a critical exposure to radiation, acute radiation syndrome includes neutropenia, nervous system damage, and pneumonia with high fatality rate.
Acute radiation syndrome occurs when the entire body is exposed.
KONEX:183490) reported on Friday the receipt of the US Food and Drug Administration (FDA) orphan Drug Designation for EC-18 for the treatment of Acute Radiation Syndrome (ARS).
CLT-008 is a first-in-class, allogeneic, cell-based therapy to treat hematopoietic sub-syndrome of Acute Radiation Syndrome (ARS).
Pluristem is targeting several therapeutics indications for which clinical trials and preclinical studies are in progress, which include: intermittent claudication, muscle regeneration critical limb ischemia, Buerger's disease, and acute radiation syndrome.
The study represents the first report of an effective radiation countermeasure for Acute Radiation Syndrome (ARS) across a broad range of lethal radiation doses when administered as late as seven days after irradiation.
Na), a novel radioprotectant being developed as a medical countermeasure for the treatment of acute radiation syndrome (ARS).
The company's vaccines/biodefense business segment includes active development programs for RiVax, a ricin toxin vaccine candidate; OrbeShield, a GI acute radiation syndrome therapeutic candidate; and SGX943, a therapeutic candidate for antibiotic resistant and emerging infectious disease.
The study will examine the effectiveness of the product as a treatment for Acute Radiation Syndrome (ARS) prior to, and within the first 24 hours of exposure to radiation.
The award will back the ongoing advanced development of CLT-008, a first-in-class, allogeneic, cell-based therapy to treat hematopoietic sub-syndrome of Acute Radiation Syndrome (ARS).
Full browser ?